Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions
Serruys PW, Ong ATL, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, James A, Bressers M, Donohoe D
free
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial
Meredith I, Ormiston J, Whitbourn R, Kay IP, Muller DW, Bonan R, Popma J, Cutlip D, Fitzgerald P, Prpic R, Kuntz R
free
One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)
Aoki J, Ong ATL, Abizaid A, den Heijer P, Bonnier H, McClean DR, Verheye S, Belardi J, Condado J, Pieper M, Eduardo Sousa J, Bressers M, Symons J, Litvack F, Sianos G, Serruys PW
free
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction.
Buszman P, Szkróbka I, Tendera Z, Gruszka A, Bialkowska B, Parma R, Wojakowski W, Król M, Kiesz SR, Bochenek A, Tendera M
free
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent
Hoye A, Ong ATL, Aoki J, van Mieghem C, Rodríguez-Granillo G, Valgimigli M, Sianos G, McFadden E, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW
free
Showing
5161
to
5175
of
5197
results
